Cellectar Biosciences

Developer of phospholipid drug conjugates (PDC) to treat cancer

placeFlorham Park, New Jersey, United States calendar_todayFounded 2002 groups15 employees language cellectar.com

Registered entities

Social engagement

Social engagement: 4.3K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record.

Investor typeCountShare
Venture capital218%
Private equity218%
Other / undisclosed764%
Coming soon